Knight Therapeutics | GUD - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Acasti Pharma USD 48.21M 16.68M 2026-06
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 952K 60K 2026-06
Aurora Cannabis CAD 76.28M 28.24M 2026-06
Avita Medical AUD 28.56M 534K 2026-06
Canopy Growth CAD 98.74M 23K 2026-06
Cronos Group USD 45.4M 1.26M 2026-06
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
IQVIA Holdings USD 3.82B 2.05B 2026-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Moderna USD 960M 817M 2026-06
Omeros USD 59.16M 20.13M 2024-06
Organigram Holdings CAD 100.45M 30.86M 2026-06
Organon & Co USD 1.19B 187M 2026-09
Revvity USD 604.27M 719K 2026-09
Tectonic Therapeutic USD 24.22M 3.08M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.68B 145.9M 2026-06
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06